Ontogeny of MMPs and TIMPs in the murine neocortex

Pediatric Research

Volumn 65, Issue 3, 2009, Pages 296-300

  Bednarek, Nathalie ^a,b,c,f   Clément, Yan ^e   Lelièvre, Vincent ^a   Olivier, Paul ^a,b   Loron, Gauthier ^a,b,c   Garnotel, Roselyne ^e   Gressens, Pierre ^a,b,d  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c Institute Alix de Champagne   (France)

^d HÔPITAL ROBERT DEBRÉ   (France)

^e UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^f REIMS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; BRAIN DEVELOPMENT; CONTROLLED STUDY; DEVELOPMENTAL STAGE; EMBRYO; ENZYME ACTIVITY; FEMALE; MALE; MOUSE; NEOCORTEX; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; ONTOGENY; PRIORITY JOURNAL; SEX DIFFERENCE; STRAIN DIFFERENCE;

AGE FACTORS; ANIMALS; ELECTROPHORESIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MALE; MATRIX METALLOPROTEINASES; MICE; MICE, MUTANT STRAINS; NEOCORTEX; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPECIES SPECIFICITY; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 61949351086     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/PDR.0b013e3181973aee     Document Type: Article

References (47)

1. Dzwonek J, Rylski M, Kaczmarek L 2004 Matrix metalloproteinases and their endogenous inhibitors in neuronal physiology of the adult brain. FEBS Lett 567:129-135
2. Cross AK, Woodroofe MN 1999 Chemokine modulation of matrix metalloproteinase and TIMP production in adult rat brain microglia and a human microglial cell line in vitro. Glia 28:183-189
3. Gottschall PE, Deb S 1996 Regulation of matrix metalloproteinase expressions in astrocytes, microglia and neurons. Neuroimmunomodulation 3:69-75
4. Pagenstecher A, Stalder AK, Kincaid CL, Shapiro SD, Campbell IL 1998 Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states. Am J Pathol 152:729-741
5. Uhm JH, Dooley NP, Oh LY, Yong VW 1998 Oligodendrocytes utilize a matrix metalloproteinase, MMP-9, to extend processes along an astrocyte extracellular matrix. Glia 22:53-63
6. Bissell MJ, Hall HG, Parry G 1982 How does the extracellular matrix direct gene expression? J Theor Biol 99:31-68
7. Adams JC, Watt FM 1993 Regulation of development and differentiation by the extracellular matrix. Development 117:1183-1198
8. Damsky CH, Werb Z 1992 Signal transduction by integrin receptors for extracellular matrix: cooperative processing of extracellular information. Curr Opin Cell Biol 4:772-781
9. Matrisian LM, Hogan BL 1990 Growth factor-regulated proteases and extracellular matrix remodeling during mammalian development. Curr Top Dev Biol 24:219-259
10. Condic ML, Letourneau PC 1997 Ligand-induced changes in integrin expression regulate neuronal adhesion and neurite outgrowth. Nature 389:852-856
11. Curran T, D'Arcangelo G 1998 Role of reelin in the control of brain development. Brain Res Brain Res Rev 26:285-294
12. Oh LY, Larsen PH, Krekoski CA, Edwards DR, Donovan F, Werb Z, Yong VW 1999 Gelatinase B/matrix metalloproteinase-9 is required for process outgrowth by Oligodendrocytes. J Neurosci 19:8464-8475
13. Larsen PH, DaSilva AG, Conant K, Yong VW 2006 Myelin formation during development of the CNS is delayed in matrix-metalloproteinase-9 and -12 null mice. J Neurosci 26:2207-2214
14. Canete-Soler R, Gui YH, Linask KK, Muschel RJ 1995 MMP-9 (gelatinase B) mRNA is expressed during mouse neurogenesis and may be associated with vascularization. Brain Res Dev Brain Res 88:37-52
15. Rivera S, Jourquin J, Ogier C, Bernard A, Charton G, Tremblay E, Khrestchatisky M 2004 [The MMP/TIMP system in the nervous system]. Med Sci (Paris) 20:55-60
16. Jourquin J, Tremblay E, Bernard A, Charton G, Chaillan FA, Marchetti E, Roman FS, Soloway PD, Dive V, Viotakis A, Khrestchatisky M 2005 Tissue inhibitor of metalloproteinases-1 (TIMP-1) modulates neuronal death, axonal plasticity, and learning and memory. Eur J Neurosci 22:2569-2578
17. Chaillan FA, Rivera S, Marchetti E, Jourquin J, Werb Z, Soloway PD, Khrestchatisky M, Roman FS 2006 Involvement of tissue inhibition of metalloproteinases-1 in learning and memory in mice. Behav Brain Res 173:191-198
18. Wang X, Jung J, Asahi M, Chwang W, Russo L, Moskowitz MA, Dixon CE, Fini ME, Lo EH 2000 Effects of matrix metalloproteinase-9 gene knock-out on morphological and motor outcomes after traumatic brain injury. J Neurosci 20:7037-7042
19. Zhao BQ, Wang S, Kim HY, Storrie H, Rosen BR, Mooney DJ, Wang X, Lo EH 2006 Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat Med 12:441-445
20. Svedin P, Hagberg H, Savman K, Zhu C, Mallard C 2007 Matrix metalloprotein-ase-9 gene knock-out protects the immature brain after cerebral hypoxia-ischemia. J Neurosci 27:1511-1518
21. Hsu JY, McKen R, Goussev S, Werb Z, Lee JU, Trivedi A, Noble-Haeusslein LJ 2006 Matrix metailoproteinase-2 facilitates wound healing events that promote functional recovery after spinal cord injury. J Neurosci 26:9841-9850
22. Rivera S, Tremblay E, Timsit S, Canals O, Ben-Ari Y, Khrestchatisky M 1997 Tissue inhibitor of metalloproteinases-1 (TIMP-1) is differentially induced in neurons and astrocytes after seizures: evidence for developmental, immediate early gene, and lesion response. J Neurosci 17:4223-4235
23. Magnoni S, Baker A. Thomson S, Jordan G, George SJ, McColl BW, McCulloch J. Horsburgh K 2007 Neuroprotective effect of adenoviral-mediated gene transfer of TIMP-1 and -2 in ischemic brain injury. Gene Ther 14:621-625
24. Birkedal-Hansen H, Cobb CM, Taylor RE, Fullmer HM 1975 Activation of latent bovine gingival collagenase. Arch Oral Biol 20:681-685
25. Docherty AJ, O'Connell J, Crabbe T, Angal S, Murphy G 1992 The matrix metalloproteinases and their natural inhibitors: prospects for treating degenerative tissue diseases. Trends Biotechnol 10:200-207
26. Ulrich R, Gerhauser I, Seeliger F, Baumgartner W, Alldinger S 2005 Matrix metalloproteinases and their inhibitors in the developing mouse brain and spinal cord: a reverse transcription quantitative polymerase chain reaction study. Dev Neurosci 27:408-418
27. Chomczynski P, Sacchi N 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Annal Biochem 162:156-159
28. Favrais G, Couvineau A, Laburthe M, Gressens P, Lelievre V 2007 Involvement of VIP and PACAP in neonatal brain lesions generated by a combined excitotoxic/ inflammatory challenge. Peptides 28:1727-1737
29. Ayoub AE, Cai TQ, Kaplan RA, Luo J 2005 Developmental expression of matrix proteinases 2 and 9 and their potential role in histogenesis of the cerebellar cortex. J Comp Neurol 481:403-415
30. Muir D 1994 Metalloproteinase dependant neunte outgrowth within a synthetic extracellular matrix is induced by nerve growth factor. Exp Cell Res 210:243-252
31. Zuo J, Ferguson TA, Hernandez YJ. Stetler-Stevenson WG, Muir D 1998 Neuronal matrix metalloproteinase-2 degrades and inactives a neurite-inhibiting chondroitin sulfate proteoglycan. J Neurosci 18:5203-5211
32. Szklarczyk A, Lapinska J. Rylski M, McKay RD, Kaczmarek L 2002 Matrix metalloproteinase-9 undergoes expression and activation during dendritic remodeling in adult hippocampus. J Neurosci 22:920-930
33. Vecil GG, Larsen PH, Corley SM, Herx LM, Besson A, Goodyer CG, Yong VW 2000 Interleukin-1 is a key regulator of matrix metalloproteinase-9 expression in human neurons in culture and following mouse brain trauma in vivo. J Neurosci Res 61:212-224
34. Rosenberg GA, Sullivan N, Esiri MM 2001 White matter damage is associated with matrix metalloproteinases in vascular dementia. Stroke 32:1162-1168
35. Sawaya RE, Yamamoto M, Gokaslan ZL, Wang SW, Mohanam S. Fuller GN. McCutcheon IE, Stetler-Stevenson WG, Nicolson GL, Rao JS 1996 Expression and localization of 72 kDa type IV collagenase (MMP-2) in human malignant gliomas in vivo. Clin Exp Metastasis 14:35-42
36. Fager N, Jaworski DM 2000 Differential spatial distribution and temporal regulation of tissue inhibitor of metalloproteinase mRNA expression during rat central nervous system development. Mech Dev 98:105-109
37. Pérez-Martinez L, Jaworski DM 2005 Tissue inhibitor of metalloproteinases-2 promotes neuronal differentiation by acting as an anti-mitogenic signal. J Neurosci 25:4917-4929
38. Okulski P, Jay TM, Jaworski J, Duniec K, Dzwonek J, Konopacki FA, Wilczynski GM, Sánchez-Capelo A, Mallet J, Kaczmarek L 2007 TIMP-1 abolishes MMP-9-dependent long-lasting long-term potentiation in the prefrontal cortex. Biol Psychiatry 62:359-362
39. Rosenberg GA 2002 Matrix metalloproteinases in neuroinflammation. Glia 39:279-291
40. Kellogg CK, Olson VG, Pleger GL 1998 Neurosteroid action at the GABAA receptor in fetal rat forebrain. Brain Res Dev Brain Res 108:131-137
41. Marin-Husstege M, Muggironi M, Raban D, Skoff RP, Casaccia-Bonnefil P 2004 Oligodendrocyte progenitor proliferation and maturation is differentially regulated by male and female sex steroid hormones. Dev Neurosci 26:245-254
42. Schaefer GB 2008 Genetics considerations in cerebral palsy. Semin Pediatr Neurol 15:21-26
43. Johnston MV, Hagberg H 2007 Sex and the pathogenesis of cerebral palsy. Dev Med Child Neurol 49:74-78
44. Hum PD, Vannucci SJ, Hagberg H 2005 Adult or perinatal brain injury: does sex matter? Stroke 36:193-195
45. Li H, Pin S, Zeng Z, Wang MM, Andreasson KA, McCullough LD 2005 Sex differences in cell death. Ann Neurol 58:317-321
46. Bona E, Hagberg H, Loberg EM, Bagenholm R, Thoresen M 1998 Protective effects of moderate hypothermia after neonatal hypoxia-ischemia: short and long term outcome. Pediatr Res 43:738-745
47. Wahlsten D 1975 Genetic variation in the development of mouse brain and behavior: evidence from the middle postnatal period. Dev Psychobiol 8:371-380